Meyer Handelman Company’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,545
| Closed | -$151K | – | 209 |
|
|
2024
Q1 | $151K | Hold |
32,545
| – | – | 0.01% | 200 |
|
|
2023
Q4 | $135K | Hold |
32,545
| – | – | 0.01% | 187 |
|
|
2023
Q3 | $97.6K | Hold |
32,545
| – | – | ﹤0.01% | 189 |
|
|
2023
Q2 | $80.1K | Hold |
32,545
| – | – | ﹤0.01% | 184 |
|
|
2023
Q1 | $73.6K | Hold |
32,545
| – | – | ﹤0.01% | 181 |
|
|
2022
Q4 | $114K | Hold |
32,545
| – | – | ﹤0.01% | 186 |
|
|
2022
Q3 | $1.21M | Hold |
32,545
| – | – | 0.06% | 136 |
|
|
2022
Q2 | $618K | Hold |
32,545
| – | – | 0.03% | 157 |
|
|
2022
Q1 | $878K | Hold |
32,545
| – | – | 0.03% | 149 |
|
|
2021
Q4 | $733K | Buy |
32,545
+4,167
| +15% | +$93.9K | 0.03% | 152 |
|
|
2021
Q3 | $744K | Hold |
28,378
| – | – | 0.03% | 156 |
|
|
2021
Q2 | $908K | Hold |
28,378
| – | – | 0.04% | 151 |
|
|
2021
Q1 | $999K | Sell |
28,378
-16,666
| -37% | -$587K | 0.04% | 149 |
|
|
2020
Q4 | $1.45M | Buy |
45,044
+16,666
| +59% | +$535K | 0.07% | 129 |
|
|
2020
Q3 | $1.07M | Hold |
28,378
| – | – | 0.05% | 132 |
|
|
2020
Q2 | $1.27M | Hold |
28,378
| – | – | 0.07% | 129 |
|
|
2020
Q1 | $968K | Sell |
28,378
-2,000
| -7% | -$68.2K | 0.06% | 129 |
|
|
2019
Q4 | $1.19M | Buy |
+30,378
| New | +$1.19M | 0.06% | 134 |
|